Last reviewed · How we verify

NCT04648358

REDUCE Trial: Perineural Dexamethasone on Scalp Nerve Blocks

Completed NA Last updated 25 January 2024
What this trial tests

NA trial testing Bupivacaine in Postoperative Pain in 156 participants. Completed in 2 January 2023.

Timeline
13 December 2020
Primary endpoint
2 January 2023
2 January 2023

Quick facts

Lead sponsorBeijing Tiantan Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment156
Start date13 December 2020
Primary completion2 January 2023
Estimated completion2 January 2023
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Beijing Tiantan Hospital

Who can join

Adults 18 to 64, any sex, with Postoperative Pain or Craniotomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pain is common in the first 2 days after major craniotomy. Inadequate analgesia may lead to an increased risk of postoperative complications. Most pain following craniotomy arises from the pericranial muscles and soft tissues of the scalp. Scalp nerve blocks with local anesthesia seem to provide effective, safe, however transient postoperative analgesia which does not seem to meet the requirements of craniotomy. Currently, peripheral dexamethasone has been observed to significantly prolong the duration of analgesia of nerve blocks (e.g., saphenous nerve block, adductor canal block, thoracic paravertebral block, brachial plexus nerve block). On the contrary, a study reported that perineural dexamethasone did not appear to prolong the analgesic time after supratentorial craniotomy. However, all patients in this study were given 24 mg of oral or intravenous dexamethasone regularly at least 7 days during the perioperative period, which possibly masked the role of single local low doses of perineural dexamethasone. Therefore, the analgesic effect of single dexamethasone for scalp nerve blocks without the backdrop of perioperative glucocorticoid deserves further clarification.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. REDUCE trial: the effects of perineural dexamethasone on scalp nerve blocks for relief of postcraniotomy pain-a study protocol for a randomized controlled trial.
    Zhao C, Jia Z, Shrestha N, Luo F. · · 2021 · cited 4× · PMID 34736497 · DOI 10.1186/s13063-021-05747-y
  2. Efficacy of Dexamethasone as an Adjuvant for Scalp Nerve Blocks to Prolong Analgesia: A Prospective, Double-Blind, Randomized Controlled Study.
    Jia Z, Shrestha N, Wang S, Zhao C, et al · · 2025 · cited 2× · PMID 39840119 · DOI 10.2147/jpr.s497029

Verify or expand the search:

Other trials of Bupivacaine

Trials testing the same drug.

Other recruiting trials for Postoperative Pain

Currently open trials in the same condition.

Other Beijing Tiantan Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04648358.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing